IBDEI0WD ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42504,1,3,0)
 ;;=3^Epistaxis
 ;;^UTILITY(U,$J,358.3,42504,1,4,0)
 ;;=4^R04.0
 ;;^UTILITY(U,$J,358.3,42504,2)
 ;;=^5019173
 ;;^UTILITY(U,$J,358.3,42505,0)
 ;;=R09.82^^127^1846^21
 ;;^UTILITY(U,$J,358.3,42505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42505,1,3,0)
 ;;=3^Postnasal Drip
 ;;^UTILITY(U,$J,358.3,42505,1,4,0)
 ;;=4^R09.82
 ;;^UTILITY(U,$J,358.3,42505,2)
 ;;=^97058
 ;;^UTILITY(U,$J,358.3,42506,0)
 ;;=K12.30^^127^1846^20
 ;;^UTILITY(U,$J,358.3,42506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42506,1,3,0)
 ;;=3^Oral Mucositis,Unspec
 ;;^UTILITY(U,$J,358.3,42506,1,4,0)
 ;;=4^K12.30
 ;;^UTILITY(U,$J,358.3,42506,2)
 ;;=^5008486
 ;;^UTILITY(U,$J,358.3,42507,0)
 ;;=J30.1^^127^1846^10
 ;;^UTILITY(U,$J,358.3,42507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42507,1,3,0)
 ;;=3^Allergic Rhinitis d/t Pollen
 ;;^UTILITY(U,$J,358.3,42507,1,4,0)
 ;;=4^J30.1
 ;;^UTILITY(U,$J,358.3,42507,2)
 ;;=^269906
 ;;^UTILITY(U,$J,358.3,42508,0)
 ;;=R09.81^^127^1846^18
 ;;^UTILITY(U,$J,358.3,42508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42508,1,3,0)
 ;;=3^Nasal Congestion
 ;;^UTILITY(U,$J,358.3,42508,1,4,0)
 ;;=4^R09.81
 ;;^UTILITY(U,$J,358.3,42508,2)
 ;;=^5019203
 ;;^UTILITY(U,$J,358.3,42509,0)
 ;;=I69.928^^127^1846^22
 ;;^UTILITY(U,$J,358.3,42509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42509,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Disease
 ;;^UTILITY(U,$J,358.3,42509,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,42509,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,42510,0)
 ;;=I69.328^^127^1846^23
 ;;^UTILITY(U,$J,358.3,42510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42510,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,42510,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,42510,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,42511,0)
 ;;=E04.0^^127^1847^39
 ;;^UTILITY(U,$J,358.3,42511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42511,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,42511,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,42511,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,42512,0)
 ;;=E04.1^^127^1847^41
 ;;^UTILITY(U,$J,358.3,42512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42512,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,42512,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,42512,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,42513,0)
 ;;=E04.2^^127^1847^40
 ;;^UTILITY(U,$J,358.3,42513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42513,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,42513,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,42513,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,42514,0)
 ;;=E01.1^^127^1847^36
 ;;^UTILITY(U,$J,358.3,42514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42514,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,42514,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,42514,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,42515,0)
 ;;=E05.00^^127^1847^56
 ;;^UTILITY(U,$J,358.3,42515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42515,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,42515,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,42515,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,42516,0)
 ;;=E05.01^^127^1847^55
 ;;^UTILITY(U,$J,358.3,42516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42516,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,42516,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,42516,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,42517,0)
 ;;=E05.90^^127^1847^58
 ;;^UTILITY(U,$J,358.3,42517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42517,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,42517,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,42517,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,42518,0)
 ;;=E05.91^^127^1847^57
 ;;^UTILITY(U,$J,358.3,42518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42518,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,42518,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,42518,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,42519,0)
 ;;=E89.0^^127^1847^50
 ;;^UTILITY(U,$J,358.3,42519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42519,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,42519,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,42519,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,42520,0)
 ;;=E03.2^^127^1847^32
 ;;^UTILITY(U,$J,358.3,42520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42520,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,42520,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,42520,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,42521,0)
 ;;=E03.9^^127^1847^33
 ;;^UTILITY(U,$J,358.3,42521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42521,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,42521,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,42521,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,42522,0)
 ;;=E06.0^^127^1847^53
 ;;^UTILITY(U,$J,358.3,42522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42522,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,42522,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,42522,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,42523,0)
 ;;=E06.1^^127^1847^54
 ;;^UTILITY(U,$J,358.3,42523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42523,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,42523,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,42523,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,42524,0)
 ;;=C73.^^127^1847^37
 ;;^UTILITY(U,$J,358.3,42524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42524,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,42524,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,42524,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,42525,0)
 ;;=E10.21^^127^1847^8
 ;;^UTILITY(U,$J,358.3,42525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42525,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,42525,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,42525,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,42526,0)
 ;;=E10.9^^127^1847^12
 ;;^UTILITY(U,$J,358.3,42526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42526,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,42526,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,42526,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,42527,0)
 ;;=E11.21^^127^1847^17
 ;;^UTILITY(U,$J,358.3,42527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42527,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,42527,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,42527,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,42528,0)
 ;;=E11.39^^127^1847^18
 ;;^UTILITY(U,$J,358.3,42528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42528,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,42528,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,42528,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,42529,0)
 ;;=E11.43^^127^1847^15
 ;;^UTILITY(U,$J,358.3,42529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42529,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,42529,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,42529,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,42530,0)
 ;;=E11.59^^127^1847^13
 ;;^UTILITY(U,$J,358.3,42530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42530,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,42530,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,42530,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,42531,0)
 ;;=E11.618^^127^1847^14
 ;;^UTILITY(U,$J,358.3,42531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42531,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,42531,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,42531,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,42532,0)
 ;;=E11.621^^127^1847^16
 ;;^UTILITY(U,$J,358.3,42532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42532,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,42532,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,42532,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,42533,0)
 ;;=E11.622^^127^1847^20
 ;;^UTILITY(U,$J,358.3,42533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42533,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,42533,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,42533,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,42534,0)
 ;;=E11.65^^127^1847^19
 ;;^UTILITY(U,$J,358.3,42534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42534,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,42534,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,42534,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,42535,0)
 ;;=E11.9^^127^1847^21
 ;;^UTILITY(U,$J,358.3,42535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42535,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,42535,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,42535,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,42536,0)
 ;;=E13.9^^127^1847^22
 ;;^UTILITY(U,$J,358.3,42536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42536,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,42536,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,42536,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,42537,0)
 ;;=E16.2^^127^1847^29
 ;;^UTILITY(U,$J,358.3,42537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42537,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,42537,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,42537,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,42538,0)
 ;;=E20.0^^127^1847^34
 ;;^UTILITY(U,$J,358.3,42538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42538,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,42538,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,42538,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,42539,0)
 ;;=E20.9^^127^1847^30
 ;;^UTILITY(U,$J,358.3,42539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42539,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,42539,1,4,0)
 ;;=4^E20.9
